These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5733268)

  • 1. [Comparative study of different platelet osmotic resistance tests].
    Ulutin ON; Balkuv S
    Tip Fak Mecm; 1968; 31(2):206-13. PubMed ID: 5733268
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on human platelets. VI. Study of platelet abnormalities by density gradient separation of platelet populations.
    Booyse FM; Hohn DC; Rafelson ME
    S Afr Med J; 1969 Aug; 43(31):964-7. PubMed ID: 5821609
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboplastic activity and content in lipids and phospholipids of platelets in polycythemia vera with associated thrombocytopathy.
    Karaca M; Stefanini M
    Am J Clin Pathol; 1967 Sep; 48(3):320-4. PubMed ID: 6034947
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet adhesiveness in polycythaemai rubra vera.
    Shield LK; Pearn JH
    Med J Aust; 1969 Apr; 1(14):711-5. PubMed ID: 5771314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polycythemia vera in childhood. Data on platelet function and blood coagulation factors].
    Esposito L; Ferrara M
    Pediatria (Napoli); 1976 Jun; 84(2):208-23. PubMed ID: 1018992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional peculiarities of thrombocytes in patients with polycythemia vera in connection with treatment with radioactive phosphorus].
    Matvienko LA
    Probl Gematol Pereliv Krovi; 1967 Jul; 12(7):28-31. PubMed ID: 5614985
    [No Abstract]   [Full Text] [Related]  

  • 7. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera].
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Orv Hetil; 1996 Jan; 137(2):71-4. PubMed ID: 8721871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
    Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on platelets. XXV. Chemical analysis of platelets from patients with congenital and acquired thrombocytopathy, with special reference to phospholipids.
    Karaca M; Stefanini M
    J Lab Clin Med; 1966 Feb; 67(2):229-45. PubMed ID: 5948180
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polycythemia vera in young adults].
    Geyer L; Nelius D; Schulz J; Spranger D
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2049-51. PubMed ID: 5144079
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
    Boneu B
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical aspects of various hemostatic platelet disorders].
    Farbiszewski R; Worowski K
    Wiad Lek; 1970 Jan; 23(1):37-42. PubMed ID: 5412430
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
    Kabutomori O; Kanakura Y; Iwatani Y
    Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of hemostasis in polycythemia vera].
    Poppa C; Enache F
    Stud Cercet Med Interna; 1972; 13(4):375-83. PubMed ID: 4644123
    [No Abstract]   [Full Text] [Related]  

  • 16. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood coagulation tests in polycythemia vera].
    Nagy G; Aszódi L; Hatvani I; Antal L
    Orv Hetil; 1968 Apr; 109(15):799-801. PubMed ID: 5701370
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet phospholipids and stypven clotting time.
    Hovmand LL; Brons K; Gormsen J
    Thromb Diath Haemorrh; 1969 Jun; 21(3):463-71. PubMed ID: 5803077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.